{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:05:56Z","timestamp":1792857956458,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methyltransferase-like 16 (METTL16) is a recently identified m6A RNA methyltransferase. Although its role in hepatocellular carcinoma has been explored, its function in metabolic dysfunction-associated steatotic liver disease (MASLD) remains elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Expression profiles of methylation-related genes were analyzed in a cohort comprising 206 MASLD patients and 10 healthy controls. Functional assays were conducted using MASLD cell models and diet-induced mouse models. Bioinformatic analyses were performed to evaluate immune cell infiltration and signaling pathway activation. Potential transcriptional regulators and small-molecule inhibitors of METTL16 were predicted through multiple databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>METTL16 expression was markedly upregulated in MASLD tissues and closely correlated with lipid metabolism-related pathways. Knockdown of METTL16 alleviated hepatic steatosis, insulin resistance, and fibrosis in high-fat diet-fed mice. Mechanistically, cell death-inducing DFF45-like effector family members A (CIDEA) was identified as a downstream mediator of METTL16-driven hepatic steatosis. Elevated hepatic METTL16 expression was associated with increased infiltration of innate immune cells, activation of immune-related signaling pathways, and upregulated expression of pro-fibrotic genes. Database mining further revealed that METTL16 may regulate immune-associated genes at both transcriptional and post-transcriptional levels. Additionally, EGR1 and MYC were identified as potential upstream transcriptional regulators of METTL16, and eleven small molecules were predicted to bind to and inhibit its biological activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>METTL16 promotes hepatic steatosis and immune-mediated fibrogenesis in MASLD. Targeting the METTL16-CIDEA axis or inhibiting METTL16 activity may serve as a promising therapeutic strategy for the treatment of MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13062-026-00760-0","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:30:23Z","timestamp":1775698223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["METTL16 promotes MASLD progression through the regulation of lipid synthesis and immune response"],"prefix":"10.1186","volume":"21","author":[{"given":"Guixin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"6","key":"760_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/apt.17158","volume":"56","author":"L Henry","year":"2022","unstructured":"Henry L, Paik J, Younossi ZM. Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world. Aliment Pharmacol Ther. 2022;56(6):942\u201356.","journal-title":"Aliment Pharmacol Ther"},{"key":"760_CR2","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.2147\/IJN.S510271","volume":"20","author":"G Li","year":"2025","unstructured":"Li G, Dai Z, Guo J. Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection. Int J Nanomed. 2025;20:3803\u201323.","journal-title":"Int J Nanomed"},{"key":"760_CR3","doi-asserted-by":"publisher","first-page":"117795","DOI":"10.1016\/j.lfs.2020.117795","volume":"254","author":"G Li","year":"2020","unstructured":"Li G, Zhang J, Jiang Q, Liu B, Xu K. CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease. Life Sci. 2020;254:117795.","journal-title":"Life Sci"},{"issue":"12","key":"760_CR4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.tem.2023.09.002","volume":"34","author":"P Luo","year":"2023","unstructured":"Luo P, Li S, Jing W, Tu J, Long X. N(6)-methyladenosine RNA modification in nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2023;34(12):838\u201348.","journal-title":"Trends Endocrinol Metab"},{"key":"760_CR5","doi-asserted-by":"publisher","first-page":"780617","DOI":"10.3389\/fendo.2021.780617","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Zhang Z, Xiang L, Zhou B, Wang X, Lin Y, et al. Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne). 2021;12:780617.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"760_CR6","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2217\/epi-2019-0009","volume":"11","author":"Z Luo","year":"2019","unstructured":"Luo Z, Zhang Z, Tai L, Zhang L, Sun Z, Zhou L. Comprehensive analysis of differences of N(6)-methyladenosine RNA methylomes between high-fat-fed and normal mouse livers. Epigenomics. 2019;11(11):1267\u201382.","journal-title":"Epigenomics"},{"key":"760_CR7","doi-asserted-by":"publisher","first-page":"973116","DOI":"10.3389\/fphar.2022.973116","volume":"13","author":"W Cheng","year":"2022","unstructured":"Cheng W, Li M, Zhang L, Zhou C, Yu S, Peng X, et al. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC. Front Pharmacol. 2022;13:973116.","journal-title":"Front Pharmacol"},{"issue":"2","key":"760_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","volume":"30","author":"Z Peng","year":"2022","unstructured":"Peng Z, Gong Y, Wang X, He W, Wu L, Zhang L, et al. METTL3-m(6)A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease. Mol Ther. 2022;30(2):932\u201346.","journal-title":"Mol Ther"},{"issue":"1","key":"760_CR9","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1038\/s41467-021-27539-3","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Yuan B, Lu M, Wang Y, Ding N, Liu C, et al. The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression. Nat Commun. 2021;12(1):7213.","journal-title":"Nat Commun"},{"issue":"3","key":"760_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jcmgh.2021.05.007","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng Y, Dong H, Sun B, Hu Y, Yang Y, Jia Y, et al. METTL3\/METTL14 Transactivation and m(6)A-Dependent TGF-\u03b21 Translation in Activated Kupffer Cells. Cell Mol Gastroenterol Hepatol. 2021;12(3):839\u201356.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"760_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.gpb.2020.06.003","volume":"18","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang Q, Cui G, Zhao F, Tian X, Sun BF, et al. m(6)A Regulates Liver Metabolic Disorders and Hepatogenous Diabetes. Genomics Proteom Bioinf. 2020;18(4):371\u201383.","journal-title":"Genomics Proteom Bioinf"},{"issue":"1","key":"760_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","volume":"518","author":"W Xie","year":"2019","unstructured":"Xie W, Ma LL, Xu YQ, Wang BH, Li SM. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism. Biochem Biophys Res Commun. 2019;518(1):120\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"760_CR13","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s10565-022-09703-7","volume":"39","author":"T Qiu","year":"2023","unstructured":"Qiu T, Wu C, Yao X, Han Q, Wang N, Yuan W, et al. AS3MT facilitates NLRP3 inflammasome activation by m(6)A modification during arsenic-induced hepatic insulin resistance. Cell Biol Toxicol. 2023;39(5):2165\u201381.","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"760_CR14","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","volume":"30","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cai J, Yang X, Wang K, Sun K, Yang Z, et al. Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. Mol Ther. 2022;30(6):2342\u201353.","journal-title":"Mol Ther"},{"key":"760_CR15","doi-asserted-by":"publisher","first-page":"145285","DOI":"10.1016\/j.scitotenv.2021.145285","volume":"770","author":"L Sun","year":"2021","unstructured":"Sun L, Gao M, Qian Q, Guo Z, Zhu P, Wang X, et al. Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m(6)A methylation level to cause lipid metabolism disorder in zebrafish. Sci Total Environ. 2021;770:145285.","journal-title":"Sci Total Environ"},{"key":"760_CR16","doi-asserted-by":"crossref","unstructured":"Tang Z, Sun C, Yan Y, Niu Z, Li Y, Xu X, et al. Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs. J Mol Cell Biol. 2023; 14(9).","DOI":"10.1093\/jmcb\/mjac061"},{"issue":"5","key":"760_CR17","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jhep.2010.08.034","volume":"54","author":"E Tybl","year":"2011","unstructured":"Tybl E, Shi FD, Kessler SM, Tierling S, Walter J, Bohle RM, et al. Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J Hepatol. 2011;54(5):994\u20131001.","journal-title":"J Hepatol"},{"issue":"1","key":"760_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/hep.31220","volume":"73","author":"B Zhou","year":"2021","unstructured":"Zhou B, Liu C, Xu L, Yuan Y, Zhao J, Zhao W, et al. N(6) -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes. Hepatology. 2021;73(1):91\u2013103.","journal-title":"Hepatology"},{"issue":"4","key":"760_CR19","doi-asserted-by":"publisher","first-page":"C762","DOI":"10.1152\/ajpcell.00212.2019","volume":"317","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liu Z, Tang H, Shen Y, Gong Z, Xie N, et al. The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA. Am J Physiol Cell Physiol. 2019;317(4):C762\u201375.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"760_CR20","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H, Hu X, Huang M, Liu J, Gu Y, Ma L, et al. Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation. Nat Commun. 2019;10(1):1898.","journal-title":"Nat Commun"},{"issue":"7667","key":"760_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"Li HB, Tong J, Zhu S, Batista PJ, Duffy EE, Zhao J, et al. m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature. 2017;548(7667):338\u201342.","journal-title":"Nature"},{"issue":"2","key":"760_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cr.2018.7","volume":"28","author":"J Tong","year":"2018","unstructured":"Tong J, Cao G, Zhang T, Sefik E, Amezcua Vesely MC, Broughton JP, et al. m(6)A mRNA methylation sustains Treg suppressive functions. Cell Res. 2018;28(2):253\u20136.","journal-title":"Cell Res"},{"issue":"13","key":"760_CR23","doi-asserted-by":"publisher","first-page":"107819","DOI":"10.1016\/j.celrep.2020.107819","volume":"31","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Zhang L, Cui XL, Yu X, Hsu PJ, Lyu R, et al. Control of Early B Cell Development by the RNA N(6)-Methyladenosine Methylation. Cell Rep. 2020;31(13):107819.","journal-title":"Cell Rep"},{"issue":"1","key":"760_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","volume":"9","author":"YF Wang","year":"2024","unstructured":"Wang YF, Zhang WL, Li ZX, Liu Y, Tan J, Yin HZ, et al. METTL14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression. Signal Transduct Target Ther. 2024;9(1):91.","journal-title":"Signal Transduct Target Ther"},{"key":"760_CR25","doi-asserted-by":"publisher","first-page":"e14379","DOI":"10.7717\/peerj.14379","volume":"10","author":"J Tang","year":"2022","unstructured":"Tang J, Zhao X, Wei W, Liu W, Fan H, Liu XP, et al. METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner. PeerJ. 2022;10:e14379.","journal-title":"PeerJ"},{"issue":"2","key":"760_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/0113892029280454240214072212","volume":"25","author":"A Mahmoudi","year":"2024","unstructured":"Mahmoudi A, Hajihasani MM, Majeed M, Jamialahmadi T, Sahebkar A. Effect of Calebin-A on Critical Genes Related to NAFLD: A Protein-Protein Interaction Network and Molecular Docking Study. Curr Genomics. 2024;25(2):120\u201339.","journal-title":"Curr Genomics"},{"key":"760_CR27","doi-asserted-by":"publisher","first-page":"217698","DOI":"10.1016\/j.canlet.2025.217698","volume":"624","author":"Z Shi","year":"2025","unstructured":"Shi Z, Cao X, Ma Y, Li K, Wang X, Lin J, et al. RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancers. Cancer Lett. 2025;624:217698.","journal-title":"Cancer Lett"},{"issue":"1","key":"760_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s11658-022-00342-8","volume":"27","author":"YZ Dai","year":"2022","unstructured":"Dai YZ, Liu YD, Li J, Chen MT, Huang M, Wang F, et al. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner. Cell Mol Biol Lett. 2022;27(1):41.","journal-title":"Cell Mol Biol Lett"},{"key":"760_CR29","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.2147\/JHC.S480522","volume":"11","author":"W Li","year":"2024","unstructured":"Li W, Zeng M, Ning Y, Lu R, Wei Y, Xu Z, et al. m(6)A-Methylated NUTM2B-AS1 Promotes Hepatocellular Carcinoma Stemness Feature via Epigenetically Activating BMPR1A Transcription. J Hepatocell Carcinoma. 2024;11:2393\u2013411.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"760_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","volume":"17","author":"J Wang","year":"2024","unstructured":"Wang J, Xiu M, Wang J, Gao Y, Li Y. METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma. J Hematol Oncol. 2024;17(1):78.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"760_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13046-023-02844-5","volume":"42","author":"N Liu","year":"2023","unstructured":"Liu N, Zhang J, Chen W, Ma W, Wu T. The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression. J Exp Clin Cancer Res. 2023;42(1):263.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"760_CR32","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s12013-024-01331-8","volume":"82","author":"N Wang","year":"2024","unstructured":"Wang N, Yang J, Liu X, Liu G, He Z, Gu S. Changes of m(6)A Regulatory Proteins and Nrf2 Signaling Molecules in Liver Tissue of Type 2 Diabetes Mellitus Rats. Cell Biochem Biophys. 2024;82(3):2217\u201326.","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"760_CR33","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1038\/s41598-019-43928-7","volume":"9","author":"A Sans","year":"2019","unstructured":"Sans A, Bonnafous S, Rousseau D, Patouraux S, Canivet CM, Leclere PS, et al. The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis. Sci Rep. 2019;9(1):7501.","journal-title":"Sci Rep"},{"issue":"2","key":"760_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41556-021-00835-2","volume":"24","author":"R Su","year":"2022","unstructured":"Su R, Dong L, Li Y, Gao M, He PC, Liu W, et al. METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis. Nat Cell Biol. 2022;24(2):205\u201316.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"760_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22(7):429\u201343.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"760_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.31713","volume":"74","author":"L Kennedy","year":"2021","unstructured":"Kennedy L, Meadows V, Sybenga A, Demieville J, Chen L, Hargrove L, et al. Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet. Hepatology. 2021;74(1):164\u201382.","journal-title":"Hepatology"},{"key":"760_CR37","doi-asserted-by":"publisher","first-page":"118178","DOI":"10.1016\/j.bmc.2025.118178","volume":"124","author":"M Liu","year":"2025","unstructured":"Liu M, Ke M, Lu H, Feng Z, Wang K, Wang D, et al. A novel cinnamic acid derivative for hepatocellular carcinoma therapy by degrading METTL16 protein. Bioorg Med Chem. 2025;124:118178.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"760_CR38","doi-asserted-by":"publisher","first-page":"33087","DOI":"10.1038\/s41598-025-16614-0","volume":"15","author":"MN Morshed","year":"2025","unstructured":"Morshed MN, Parvez SA, Akanda RI, Saha MK, Fardous J, Alam M, et al. Identification of novel small molecule inhibitors targeting multiple methyltransferase like proteins against hepatocellular carcinoma. Sci Rep. 2025;15(1):33087.","journal-title":"Sci Rep"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00760-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00760-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00760-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:39:03Z","timestamp":1781645943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00760-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00760-0","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were conducted in strict accordance with the guidelines approved by the Institutional Animal Care and Ethics Committee (Approval No.AD2022189). The use of human liver specimens in this study was approved by the Ethics Committee of Shanghai Sixth People\u2019s Hospital (Approval No. 2020-069).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}